Who makes HKT-500 Topical Patch?

HKT-500 Topical Patch is developed by Hisamitsu Pharmaceutical Co., Inc..

What development phase is HKT-500 Topical Patch in?

HKT-500 Topical Patch is in Phase 2.

Last reviewed 2026-04-23 · How we verify

HKT-500 Topical Patch

Hisamitsu Pharmaceutical Co., Inc. · Phase 2 active Small molecule

At a glance

Generic name	HKT-500 Topical Patch
Also known as	HKT-500, Ketoprofen
Sponsor	Hisamitsu Pharmaceutical Co., Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

HKT-500-US12 In Adult Patients With OA Knee Pain (PHASE2)
HKT-500 in the Treatment of Adult Patients With Ankle Sprain (PHASE3)
HKT-500 in Adult Patients With Shoulder Pain (PHASE3)
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain (PHASE3)
HKT-500 in Adult Patients With Ankle Sprain (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HKT-500 Topical Patch CI brief — competitive landscape report
HKT-500 Topical Patch updates RSS · CI watch RSS
Hisamitsu Pharmaceutical Co., Inc. portfolio CI